Observational Study in People with CF with the G551D mutation
Funding for this trial has been provided in full or in part by Cystic Fibrosis Foundation Therapeutics, Inc.
Number of Participants Being Recruited:
Single / Multi-Center:
STUDY BACKGROUND INFORMATION:
The goal of this research study was to collect blood, urine, and sputum samples to be stored for future research. This is called specimen banking. Information about the amount of salt in sweat, and information about health such as lung function, weight and questionnaires was also collected. Researchers for future cystic fibrosis research may use the banked specimens and the health information to develop tests that could be used to help identify additional drugs that can help people with CF. At specific study sites people participated in sub-studies that involved additional procedures such as sweat rate testing, ability to clear mucus from the lungs, induced sputum collection, or taking a gastrointestinal pH pill.
>= 6 Years
P. aeruginosa status:
B. cepacia status:
Other Primary Eligibility Requirements:
Must have the G551D-CFTR mutation on at least 1 allele (any known or unknown mutations allowed in second allele).
Note: Detailed eligibility criteria information may be available on clinicaltrials.gov. If a specific
trial listing for this trial is available, a link to the specific clinicaltrials.gov listing will be present in the "More Information" section below.